NHC reported FY 2025 net operating revenues of USD 1.5 billion, up 16.1%, including net patient revenues of USD 1.5 billion (+17.4%) and other revenues of USD 48.2 million (+4.3%). Income from operations was USD 128.4 million, and income before income taxes was USD 162.4 million (+19.1%). Net income attributable to common stockholders was USD 120.0 million (+17.7%), with GAAP diluted EPS of USD 7.67 and non-GAAP diluted EPS of USD 6.65. For FY 2025, NHC said skilled nursing occupancy (based on operational beds) was 89.7% (vs. 88.6% in FY 2024) and the composite skilled nursing facility per diem increased 4.0%. The company highlighted the full-year contribution from the White Oak acquisition (closed August 1, 2024), which contributed USD 227.5 million of FY 2025 net patient revenues and added 15 skilled nursing facilities (1,928 licensed beds), two assisted living facilities (48 units), four independent living facilities (302 units), and a long-term care pharmacy in South Carolina and North Carolina. NHC also reported FY 2025 cash provided by operating activities of USD 185.1 million and ended the year with USD 112.2 million in cash, cash equivalents, restricted cash, and restricted cash equivalents.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. National Healthcare Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-005910), on February 26, 2026, and is solely responsible for the information contained therein.
Comments